{
  "id": "d9177723-423c-4876-9559-4c5554bb5fe0",
  "answer": "Regeneron Pharmaceuticals, Inc. has a balanced company news read. Its latest completed weekly trend is negative.",
  "status": "balanced",
  "as_of": "2026-08-16T02:42:30.885055+00:00",
  "period_end": "2026-08-14",
  "scope": "company and instrument",
  "subject": {
    "type": "ticker",
    "key": "GER:RGO",
    "name": "Regeneron Pharmaceuticals, Inc. (RGO)",
    "identity": {
      "sharemaestro_id": "cdb53169-f08e-4509-9fef-82424c1bca56",
      "canonical_name": "Regeneron Pharmaceuticals, Inc.",
      "isin": null,
      "lei": null,
      "cik": null,
      "website": null,
      "aliases": [
        "RGO"
      ],
      "provider_symbols": {
        "eodhd": [
          "RGO.XETRA",
          "RGO.F",
          "RGO.DU",
          "RGO.MU",
          "RGO.HM",
          "RGO.HA",
          "RGO.BE",
          "RGO.STU"
        ],
        "yahoo": "RGO.DE",
        "market": "GER",
        "alpha_vantage": null
      },
      "same_as": []
    }
  },
  "coverage": {
    "country": "Germany",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "score": 47.0,
  "confidence": 24,
  "evidence_count": 13,
  "independent_sources": 4,
  "freshest_evidence": "2026-08-14T22:23:52+00:00",
  "previous_read": 47.0,
  "change": 0.0,
  "method_version": "public-evidence-1",
  "facts": {
    "sector": "Healthcare",
    "ticker": "RGO",
    "company": "Regeneron Pharmaceuticals, Inc.",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "GER",
    "industry": "Biotechnology",
    "week_end": "2026-08-14",
    "asset_type": "equity",
    "news_count": 13,
    "trend_state": "negative",
    "latest_close": "693.599976",
    "score_change": 0.0,
    "weekly_change": 3.0,
    "evidence_status": "provisional",
    "sentiment_score": 47
  },
  "canonical_url": "https://sharemaestro.com/evidence/d9177723-423c-4876-9559-4c5554bb5fe0/",
  "evidence_urls": [
    {
      "label": "Company chart",
      "url": "https://sharemaestro.com/terminal/cdb53169-f08e-4509-9fef-82424c1bca56/"
    },
    {
      "label": "Company news sentiment",
      "url": "https://sharemaestro.com/sentiment/cdb53169-f08e-4509-9fef-82424c1bca56/"
    },
    {
      "label": "Current financial news",
      "url": "https://sharemaestro.com/newsreel/search/?ticker=RGO"
    }
  ],
  "limitations": "This is dated market research. Coverage may be delayed, incomplete or unavailable.",
  "record_hash": "d33221329ba4ec5bd09e6237293755c6ac41a2f16a792fa08408e617197df571",
  "citation": "Sharemaestro, Regeneron Pharmaceuticals, Inc. (RGO), 2026-08-16, https://sharemaestro.com/evidence/d9177723-423c-4876-9559-4c5554bb5fe0/"
}